Status | Study |
Completed |
Study Name: Intensity-Modulated Radiation Therapy, Cisplatin, and Bevacizumab Followed by Carboplatin and Paclitaxel in Treating Patients Who Have Undergone Surgery for Endometrial Cancer Condition: Endometrial Adenocarcinoma Endometrial Adenosquamous Cell Carcinoma Date: 2009-10-29 Interventions: Radiation: intensity-modulated radiation therapy |
Completed |
Study Name: Bevacizumab and Aldesleukin in Treating Patients With Metastatic Clear Cell Carcinoma of the Kidney Condition: Kidney Cancer Date: 2009-02-26 Interventions: Biological: aldesleukin SQ Ald |
Completed |
Study Name: Safety and Efficacy of Bevacizumab Plus RAD001 Versus Interferon Alfa-2a and Bevacizumab for the First-line Treatment in Adult Patients With Kidney Cancer Condition: Carcinoma Adenocarcinoma Renal Cell Date: 2008-07-15 Interventions: Drug: RAD001(everolimus) 10 mg |
Completed |
Study Name: AMG 386, 20060159 Phase 2, RCC 1st Line in Combination With Sorafenib Condition: Advanced Renal Cell Carcinoma Date: 2007-04-26 Interventions: Drug: AMG 386 3 mg/kg or 10mg/ |
Completed |
Study Name: High-dose Bevacizumab in Advanced Renal Carcinoma Patients Condition: Renal Cancer Kidney Cancer Date: 2007-04-03 Interventions: Drug: Bevacizumab Bevacizumab Other Name: Avastin |
Completed |
Study Name: Whole-Abdominal Radiation Therapy and Cisplatin in Treating Patients With Stage III or Stage IV Endometrial Cancer That Has Been Removed by Surgery Condition: Endometrial Cancer Date: 2007-03-15 Interventions: Radiation: Vaginal Brachytherapy |
Active, not recruiting |
Study Name: Fludeoxyglucose F 18 PET Scan, CT Scan, and Ferumoxtran-10 MRI Scan Before Chemotherapy and Radiation Therapy in Finding Lymph Node Metastasis in Patients With Locally Advanced Cervical Cancer or High-Risk Endometrial Cancer Condition: Cervical Adenocarcinoma Cervical Adenosquamous Cell Carcinoma Date: 2006-12-27 Interventions: Radiation: fludeoxyglucose F 18 |
Terminated |
Study Name: A Pilot Study of Celecoxib in Patients With Grade 2 or 3 Uterine Cancers Condition: Uterine Cancer Date: 2005-09-30 Interventions: Drug: Celecoxib |
Completed |
Study Name: Temsirolimus in Treating Patients With Metastatic or Locally Advanced Recurrent Endometrial Cancer Condition: Endometrial Adenocarcinoma Endometrial Adenosquamous Cell Carcinoma Date: 2003-11-04 Interventions: Drug: temsirolimus Given IV |
Completed |
Study Name: ABR-217620 in Patients With Advanced Non-Small Cell Lung Cancer, Renal Clear Cell Carcinoma or Pancreatic Cancer Condition: Non-Small-Cell Lung Carcinoma Renal Cell Carcinoma Pancrea Date: 2003-03-16 Interventions: Drug: ABR-217620 Starting dose: 0.5 mcg/kg; subsequent doses: individual, based on pre-treatment level o |